Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Amarin Corporation PLC to Contact the Firm NEW YORK, NY -- (Marketwired) -- 11/15/13 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amarin Corporation PLC ("Amarin" or the "Company") (NASDAQ: AMRN) of the January 3, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Amarin and certain executives. A complaint has been filed on behalf of all persons who purchased Amarin common stock between July 9, 2009 and October 15, 2013 (the "Class Period") in the District of New Jersey. The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects. Specifically, the action alleges that throughout the Class Period, Amarin issued false and/or misleading statements regarding the prospects of the FDA approving Vascepa, the Company's lead product. On October 16, 2013, Amarin announced that the FDA's Endrocrinologic and Metabolic Drugs Advisory Committee had voted 9 to 2 against approval of Vascepa. Following this news, the Company's stock declined $3.16 per share, or over 61%, to close at $2.01 per share on October 17, 2013. Request more information now by clicking here: www.faruqilaw.com/AMRN. There is no cost or obligation to you. Take Action If you invested in Amarin stock or options between July 9, 2009 and October 15, 2013 and would like to discuss your legal rights, visit www.faruqilaw.com/AMRN. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Amarin's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. FARUQI & FARUQI, LLP 369 Lexington Avenue, 10th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. email@example.com Francis McConville, Esq. firstname.lastname@example.org Telephone: (877) 247-4292 or (212) 983-9330
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Amarin Corporation PLC to
Press spacebar to pause and continue. Press esc to stop.